Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Yes, most women aged 50 and older are advised to get two doses of the recombinant shingles vaccine (Shingrix), spaced two to six months apart, because it is more than 90% effective at preventing shingles and postherpetic neuralgia, a lasting nerve pain that affects women more often than men. Risk rises sharply with age since immunity to the chickenpox virus fades over time, and vaccination is recommended even if you have already had shingles, had the older Zostavax vaccine, or do not recall having chickenpox. Timing may differ if you are pregnant, currently have a shingles rash, are immunocompromised, or take certain medications, and there are several other factors to consider before scheduling your doses, which are explained below. If you are currently dealing with a painful rash, tingling, burning skin, or unexplained nerve pain, knowing whether it could be shingles matters, because antiviral treatment works best within 72 hours of the first symptoms. Take a free, instant, online symptom check to better understand what your symptoms could mean and what step to take next.
Last reviewed for medical accuracy: 09/24/2026
Should Women Over 50 Get the Shingles Vaccine?
As you move past age 50, your immune system naturally weakens, and the varicella-zoster virus (which causes chickenpox) can reactivate as shingles. Shingles is more than a skin rash—it can cause severe pain and, in some cases, long-term complications. For women over 50, vaccination offers strong protection. Below, we explain what shingles looks like, why women over 50 face higher risk, and how the vaccine can help you stay healthy and pain-free.
What Is Shingles?
Shingles (herpes zoster) is a viral infection that appears as a painful, blistering rash. After you’ve had chickenpox, the virus remains dormant in nerve cells. Years later, it can wake up and travel along nerves to your skin surface.
Common shingles rash symptoms include:
Beyond the rash, shingles can also cause:
Why Women Over 50 Are at Higher Risk
Your risk of shingles roughly doubles after age 50 and keeps rising. Key factors for women include:
Statistics show up to one in three people will experience shingles in their lifetime—and the majority are over 50. Women often report more severe pain and a higher rate of postherpetic neuralgia than men, making prevention especially important.
How the Shingles Vaccine Works
Two vaccines are available, but the recombinant zoster vaccine (Shingrix) is the preferred choice for anyone over 50:
• Shingrix (two doses, 2–6 months apart)
• Zostavax (single dose; less effective, used less often)
Shingrix uses a non-live viral component plus an adjuvant to boost your immune response. Clinical trials show Shingrix is:
Benefits of Getting Vaccinated
• Dramatically lowers your chance of developing shingles
• Reduces severity and duration if you do get shingles
• Cuts risk of postherpetic neuralgia, the most troublesome long-term complication
Safety and Side Effects
Shingrix is generally well tolerated. Most side effects are mild to moderate and resolve within a few days. They include:
Serious allergic reactions are very rare. If you have a history of severe allergic reactions to vaccine ingredients or are immunocompromised, discuss timing and suitability with your doctor.
Recognizing Shingles Rash Symptoms Early
Early diagnosis and antiviral treatment can shorten the course of shingles and reduce complications. If you notice any of these shingles rash symptoms, consider acting quickly:
If you’re unsure whether your symptoms match shingles, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide if you need to see a healthcare provider.
Special Considerations for Women Over 50
While most healthy women over 50 should get vaccinated, certain factors merit discussion with your doctor:
Insurance and Cost
Most insurance plans, including Medicare Part D, cover the shingles vaccine with little or no out-of-pocket cost. Check with your plan administrator about coverage and preferred pharmacies or clinics.
Making the Decision: Key Questions to Ask Your Doctor
Speak to your doctor about anything that could be life-threatening or serious. They can help tailor a plan that fits your individual health needs.
Bottom Line
For most women over 50, the shingles vaccine is a safe, effective way to prevent painful outbreaks and long-term complications. By getting vaccinated, you greatly reduce your odds of suffering the blistering rash and intense nerve pain that shingles can bring.
If you experience any concerning shingles rash symptoms or are unsure whether vaccination is right for you, don’t hesitate to check your symptoms. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
Remember: prevention is far better than treatment. Talk with your healthcare provider to decide on the best timing for vaccination, and protect yourself against shingles today.
Speak to a doctor about anything that could be life-threatening or serious.
(References)
* Callegaro A, Curran D, Matthews S. Burden-of-illness vaccine efficacy. Pharm Stat. 2020 Sep;19(5):636-645. doi: 10.1002/pst.2020. Epub 2020 Mar 27. PMID: 32220002; PMCID: PMC9291914.
* Cohen EJ, Jeng BH. Herpes Zoster: A Brief Definitive Review. Cornea. 2021 Aug 1;40(8):943-949. doi: 10.1097/ICO.0000000000002754. PMID: 34029242; PMCID: PMC8249351.
* Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, Duffy J, Glanz J, Naleway A, Donahue JG, Klein NP. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Ann Intern Med. 2024 Feb;177(2):189-195. doi: 10.7326/M23-2023. Epub 2024 Jan 9. PMID: 38190712; PMCID: PMC11001419.
* Shah S, Dahal K, Thapa S, Subedi P, Paudel BS, Chand S, Salem A, Lammle M, Sah R, Krsak M. Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis. Brain Behav. 2024 Feb;14(2):e3415. doi: 10.1002/brb3.3415. PMID: 38687552; PMCID: PMC10839537.
* Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024 Oct;30(10):2777-2781. doi: 10.1038/s41591-024-03201-5. Epub 2024 Jul 25. PMID: 39053634; PMCID: PMC11485228.
* Lim DZJ, Tey HL, Salada BMA, Oon JEL, Seah ED, Chandran NS, Pan JY. Herpes Zoster and Post-Herpetic Neuralgia-Diagnosis, Treatment, and Vaccination Strategies. Pathogens. 2024 Jul 17;13(7). doi: 10.3390/pathogens13070596. Epub 2024 Jul 17. PMID: 39057822; PMCID: PMC11280284.
* Krasselt M, Trawinski H, Lübbert C. [Zoster vaccination]. Inn Med (Heidelb). 2024 Nov;65(11):1092-1098. doi: 10.1007/s00108-024-01764-6. Epub 2024 Aug 28. PMID: 39196355.
* Tang E, Ray I, Arnold BF, Acharya NR. Recombinant zoster vaccine and the risk of dementia. Vaccine. 2025 Feb 6;46:126673. doi: 10.1016/j.vaccine.2024.126673. Epub 2024 Dec 28. PMID: 39733478; PMCID: PMC11969937.
* Eyting M, Xie M, Michalik F, Heß S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025 May;641(8062):438-446. doi: 10.1038/s41586-025-08800-x. Epub 2025 Apr 2. PMID: 40175543; PMCID: PMC12058522.
* Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025 Jun 17;333(23):2083-2092. doi: 10.1001/jama.2025.5013. PMID: 40267506; PMCID: PMC12019675.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.